Prof. Dr. Jens Huober
Chefarzt/Chefärztin
Brustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I
Vergleich von Docetaxel mit Paclitaxel beim metastasierenden Mammakarzinom
Huober J. Vergleich von Docetaxel mit Paclitaxel beim metastasierenden Mammakarzinom. Geburtsh Frauenheilk 2006; 66:87-89.
01.01.2006Vergleich von Docetaxel mit Paclitaxel beim metastasierenden Mammakarzinom
01.01.2006Geburtsh Frauenheilk 2006; 66:87-89
Huober Jens
Endocrine treatment of metastastic breast cancer
Gerber B, Huober J. Endocrine treatment of metastastic breast cancer. Breast Care 2006; 1:248-251.
01.01.2006Endocrine treatment of metastastic breast cancer
01.01.2006Breast Care 2006; 1:248-251
Gerber B, Huober Jens
Metastastic breast cancer - highlights at ASCO 2006
Huober J. Metastastic breast cancer - highlights at ASCO 2006. Breast Care 2006; 1:270-273.
01.01.2006Metastastic breast cancer - highlights at ASCO 2006
01.01.2006Breast Care 2006; 1:270-273
Huober Jens
Non-enrolment of ovarian cancer patients in clinical trials: reasons and background
Harter P, Staehle A, Huober J, Schmalfeldt B, Gropp M, Wollschlaeger K, Burges A, Schade-Brittinger C, du Bois A, Pfisterer J. Non-enrolment of ovarian cancer patients in clinical trials: reasons and background. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005; 16:1801-5.
01.11.2005Non-enrolment of ovarian cancer patients in clinical trials: reasons and background
01.11.2005Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005; 16:1801-5
Harter P, Staehle A, Huober Jens, Schmalfeldt B, Gropp M, Wollschlaeger K, Burges A, Schade-Brittinger C, du Bois A, Pfisterer J
The role of surgery in recurrent ovarian cancer
Pfisterer J, AGO Ovarian Committee, Bois A, Fink D, Huober J, Gropp M, Loibl S, Burges A, Hasenburg A, Hahmann M, Jackisch C, Richter B, Canzler U, Harter P, AGO Ovarian Cancer Study Group (AGO-OVAR). The role of surgery in recurrent ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005; 15 Suppl 3:195-8.
01.01.2005The role of surgery in recurrent ovarian cancer
01.01.2005International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005; 15 Suppl 3:195-8
Pfisterer J, AGO Ovarian Committee, Bois A, Fink D, Huober Jens, Gropp M, Loibl S, Burges A, Hasenburg A, Hahmann M, Jackisch C, Richter B, Canzler U, Harter P, AGO Ovarian Cancer Study Group (AGO-OVAR)
Neue Aspekte der adjuvanten Theraphie beim Mammakarzinom - die Aromatasehemmer
Krauss K, Wallwiener D, Huober J. Neue Aspekte der adjuvanten Theraphie beim Mammakarzinom - die Aromatasehemmer. Geburtsh Frauenheilk 2005; 65:803-805.
01.01.2005Neue Aspekte der adjuvanten Theraphie beim Mammakarzinom - die Aromatasehemmer
01.01.2005Geburtsh Frauenheilk 2005; 65:803-805
Krauss K, Wallwiener D, Huober Jens
Neoadjuvant therapy with gemcitabine in breast cancer
Schneeweiss A, Bastert G, Huober J, Wallwiener D, Hamerla R, Lichter P. Neoadjuvant therapy with gemcitabine in breast cancer. Oncology (Williston Park, N.Y.) 2004; 18:27-31.
01.12.2004Neoadjuvant therapy with gemcitabine in breast cancer
01.12.2004Oncology (Williston Park, N.Y.) 2004; 18:27-31
Schneeweiss Andreas, Bastert Gunther, Huober Jens, Wallwiener Diethelm, Hamerla Rainer, Lichter Peter
Neoadjuvant endocrine therapy in primary breast cancer
Huober J, Krainick-Strobel U, Kurek R, Wallwiener D. Neoadjuvant endocrine therapy in primary breast cancer. Clinical breast cancer 2004; 5:341-7.
01.12.2004Neoadjuvant endocrine therapy in primary breast cancer
01.12.2004Clinical breast cancer 2004; 5:341-7
Huober Jens, Krainick-Strobel Ute, Kurek Raffael, Wallwiener Diethelm
Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study
Schneeweiss A, Wallwiener D, Hamerla R, Solomayer E, Krauss K, Beldermann F, Rudlowski C, von Fournier D, Sinn H, Huober J, Bastert G. Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study. European journal of cancer (Oxford, England : 1990) 2004; 40:2432-8.
01.11.2004Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study
01.11.2004European journal of cancer (Oxford, England : 1990) 2004; 40:2432-8
Schneeweiss A, Wallwiener D, Hamerla R, Solomayer E, Krauss K, Beldermann F, Rudlowski C, von Fournier D, Sinn H-P, Huober Jens, Bastert G
Chemotherapy of breast cancer-additive anticancerogenic effects by 2-methoxyestradiol?
Mueck A, Seeger H, Huober J. Chemotherapy of breast cancer-additive anticancerogenic effects by 2-methoxyestradiol?. Life sciences 2004; 75:1205-10.
23.07.2004Chemotherapy of breast cancer-additive anticancerogenic effects by 2-methoxyestradiol?
23.07.2004Life sciences 2004; 75:1205-10
Mueck A O, Seeger H, Huober Jens
Value of positron emission tomography scan in staging cancers, and an unusual presentation of acute myeloid leukemia. Case 2. Detection of an appendiceal carcinoma by whole-body positron emission tomography after Caesarean section
Krauss K, Aydeniz B, Dohmen B, Wehrmann M, Wallwiener D, Huober J. Value of positron emission tomography scan in staging cancers, and an unusual presentation of acute myeloid leukemia. Case 2. Detection of an appendiceal carcinoma by whole-body positron emission tomography after Caesarean section. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004; 22:2966-8.
15.07.2004Value of positron emission tomography scan in staging cancers, and an unusual presentation of acute myeloid leukemia. Case 2. Detection of an appendiceal carcinoma by whole-body positron emission tomography after Caesarean section
15.07.2004Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004; 22:2966-8
Krauss K, Aydeniz B, Dohmen B M, Wehrmann M, Wallwiener D, Huober Jens
Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen
Seeger H, Huober J, Wallwiener D, Mueck A. Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2004; 36:277-80.
01.05.2004Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen
01.05.2004Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2004; 36:277-80
Seeger H, Huober Jens, Wallwiener D, Mueck A O
Vaccination of patients with advanced ovarian carcinoma with the anti-idiotype ACA125: immunological response and survival (phase Ib/II)
Reinartz S, Sabbatini P, DuBois A, Kreienberg R, Möbus V, Huober J, Renke K, Giffels P, Krista K, Schlebusch H, Köhler S, Wagner U. Vaccination of patients with advanced ovarian carcinoma with the anti-idiotype ACA125: immunological response and survival (phase Ib/II). Clinical cancer research : an official journal of the American Association for Cancer Research 2004; 10:1580-7.
01.03.2004Vaccination of patients with advanced ovarian carcinoma with the anti-idiotype ACA125: immunological response and survival (phase Ib/II)
01.03.2004Clinical cancer research : an official journal of the American Association for Cancer Research 2004; 10:1580-7
Reinartz Silke, Sabbatini Paul, DuBois Andreas, Kreienberg Rolf, Möbus Volker, Huober Jens, Renke Kirsten, Giffels Patrick, Krista Karl, Schlebusch Harald, Köhler Siegmund, Wagner Uwe
Is the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer? Preliminary in vitro investigations
Mueck A, Seeger H, Wallwiener D, Huober J. Is the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer? Preliminary in vitro investigations. European journal of gynaecological oncology 2004; 25:699-701.
01.01.2004Is the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer? Preliminary in vitro investigations
01.01.2004European journal of gynaecological oncology 2004; 25:699-701
Mueck A O, Seeger H, Wallwiener D, Huober Jens
Überblick über die neoadjuvante endokrine Theraphie des rezeptorpositiven Mammakarzinoms der postmenopausalen Frau
Paepke S, Eiermann W, Wolf C, Huober J, Warm M, Blohmer J, Diedrich F, Fischer T, Pildner v Steinburg S, Schwarz-Böger U, Jacobs V, Harbeck N, Kiechle M. Überblick über die neoadjuvante endokrine Theraphie des rezeptorpositiven Mammakarzinoms der postmenopausalen Frau. Geburtsh Frauenheilk 2004; 64:1290-1298.
01.01.2004Überblick über die neoadjuvante endokrine Theraphie des rezeptorpositiven Mammakarzinoms der postmenopausalen Frau
01.01.2004Geburtsh Frauenheilk 2004; 64:1290-1298
Paepke S, Eiermann W, Wolf C, Huober Jens, Warm M, Blohmer J, Diedrich F, Fischer T, Pildner v Steinburg S, Schwarz-Böger U, Jacobs VR, Harbeck N, Kiechle M
Aktueller Stellenwert des Ultraschalls in der Mammadiagnostik
Krainick-Strobel U, Bergmann A, Huober J, Wallwiener D. Aktueller Stellenwert des Ultraschalls in der Mammadiagnostik. Geburtsh Frauenheilk 2004; 64:632-633.
01.01.2004Aktueller Stellenwert des Ultraschalls in der Mammadiagnostik
01.01.2004Geburtsh Frauenheilk 2004; 64:632-633
Krainick-Strobel U, Bergmann A, Huober Jens, Wallwiener D
Effect of tamoxifen and 2-methoxyestradiol alone and in combination on human breast cancer cell proliferation
Seeger H, Diesing D, Gückel B, Wallwiener D, Mueck A, Huober J. Effect of tamoxifen and 2-methoxyestradiol alone and in combination on human breast cancer cell proliferation. The Journal of steroid biochemistry and molecular biology 2003; 84:255-7.
01.02.2003Effect of tamoxifen and 2-methoxyestradiol alone and in combination on human breast cancer cell proliferation
01.02.2003The Journal of steroid biochemistry and molecular biology 2003; 84:255-7
Seeger H, Diesing D, Gückel B, Wallwiener D, Mueck A O, Huober Jens
Chemotheraphie des Endometriumkarzinoms
Huober J, Gruber I, Fehm T. Chemotheraphie des Endometriumkarzinoms. Onkologe 2003; 9:1241-1244.
01.01.2003Chemotheraphie des Endometriumkarzinoms
01.01.2003Onkologe 2003; 9:1241-1244
Huober Jens, Gruber I, Fehm T
St. Gallen 2003 - Was tun?
Wallwiener D, Huober J. St. Gallen 2003 - Was tun?. Frauenarzt 2003; 44:516-517.
01.01.2003St. Gallen 2003 - Was tun?
01.01.2003Frauenarzt 2003; 44:516-517
Wallwiener D, Huober Jens
[CD80-modified tumor cell lines: implications for cell-based vaccinations in breast cancer patients]
Gückel B, Stumm S, Kayser S, Rentzsch C, Gruber I, Marmé A, Huober J, Meuer S, Wallwiener D. [CD80-modified tumor cell lines: implications for cell-based vaccinations in breast cancer patients]. Zentralblatt für Gynäkologie 2002; 124:566-73.
01.12.2002[CD80-modified tumor cell lines: implications for cell-based vaccinations in breast cancer patients]
01.12.2002Zentralblatt für Gynäkologie 2002; 124:566-73
Gückel B, Stumm S, Kayser S, Rentzsch C, Gruber I, Marmé A, Huober Jens, Meuer S C, Wallwiener D